New Research Affirms U=U | |
 | The PARTNER2 study provides the most definitive data yet that the concept of U=U (undetectable equals untransmittable) is objective truth -- for MSM and heterosexuals alike. |
Getting Real About Long-Acting ART | |
 | Anton Pozniak, M.D., explores a critical question around long-acting antiretrovirals: Once viable options have reached the market, what will be their true impact? |
PrEP: Every Day, or on Demand? | |
 | Interim results from the Prévenir study suggest that, for men who have sex with men, either dosing approach can be successful. |
Dolutegravir and Pregnancy: What's the Risk? | |
 | Lynn Mofenson, M.D., of the Elizabeth Glaser Pediatric AIDS Foundation discusses recent findings on babies born with neural tube defects to women living with HIV. |
An ongoing series to help providers set the foundations of a patient's care.
What's New or Notable in HIV Treatment and Prevention Adherence?
Progress and Gaps in Scaling Up Universal HIV Treatment in Africa
Starting HIV Treatment Soon After Diagnosis Trims Time to Viral Suppression
What's the Next Game-Changer in HIV Treatment?
The field of hepatitis C disease management is in the midst of dramatic change. This series provides overviews, research updates, and more.
Hepatitis C: How Is It Transmitted and Who Should Be Tested?
Addressing Hepatitis C Treatment Barriers Among HCV/HIV-Coinfected Patients
What Are the Hepatitis C Genotypes?
Hepatitis C Resources, Services and Information
High-Risk Youth in Lower-Income Countries Who Inject Drugs: Challenges and Opportunities
Sex and the HIV Reservoir: New Research Points to the Powerful Effect of Estrogen
This Week in HIV Research: Treatment Does a Body Good
Helping Providers Increase Capacity to Care for Patients on PrEP
HIV PrEP in the U.S. Military Services
HIV-Related Stigma and Discrimination: New Insights for Effective Interventions From AIDS 2018
Why Has HIV in Saskatchewan Become More Harmful for Some People?
This Week in HIV Research: Another Notch in the "Treatment as Prevention" Belt
Issues Unrelated to HIV Are Affecting Survival
For Transgender Women, PrEP Is Safe to Use With Estradiol as Feminizing Hormone Therapy, Study Says
Lynne Mofenson, M.D., Explains the Dolutegravir Risks for People With HIV Who Want to Get Pregnant
Dolutegravir-Based Two-Drug Regimen Just as Good for HIV Treatment as Three-Drug Therapy, Study Says
Why Caring for People With HIV Is Still Great
HIV Activist David Barr on Going Beyond 90-90-90
The Thrill of Curing Hepatitis C and the Pain of Watching the Disease Surge With Opioid Abuse
Gay Men Cannot Get HIV From Partners Who Are Virally Suppressed, New Study Proves
PrEP Before and After Sex Worked as Well as Daily PrEP in Preventing HIV, New Study Finds
How Will Long-Acting HIV Antiretrovirals Work in the Real World?
This Week in HIV Research: At-Home PrEP Care Advances
This Week in HIV Research: A Yawning Racial Gap in U.S. Testing
FDA Approves First PI-based Single-Tablet Treatment for HIV -- How Will It Be Used?
UNAIDS Warns That Progress Is Slowing and Time Is Running Out to Reach the 2020 HIV Targets
To Breastfeed or Not to Breastfeed While Living With HIV? Data Needed!
Symtuza: FDA Approves New Fixed-Dose Combination for Treatment of HIV
© 2018 Remedy Health Media, LLC. All Rights Reserved
TheBodyPRO: About TheBodyPRO | Contact TheBodyPRO | Content Policy | Advertise With Us
Remedy Health Media: About Remedy Health Media | Contact Remedy Health Media | Terms of Use | Privacy Policy
TheBodyPRO is a service of Remedy Health Media, 461 Fifth Avenue, 14th Floor, New York, NY 10017. TheBodyPRO and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of TheBodyPRO's homepage, topic pages, page designs and HTML code. General Disclaimer: TheBodyPRO is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBodyPRO should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
